|
|
|
|
|
|
by i000
3706 days ago
|
|
|
As someone who works at the bioinformatics end of a clinical cancer sequencing operation, and someone familiar with the MSKCC operation (they are doing good work with their IMPACT assay) I have to say that the landscape of matching patients with drugs is so sparse (few drugs, few FDA-approved links, not enough trials) that no Watson is necessary, just basic string matching and a comprehensive high-quality up-to-date database (which does not exist and currently there are 10+ companies working on it) |
|
|